Skip to main content

Clifford Chance

Clifford Chance

News and awards

Clifford Chance advises Cinven on its acquisition of Labco

28 May 2015

Clifford Chance advises Cinven on its acquisition of Labco

International law firm Clifford Chance has advised European private equity firm Cinven on its agreement to acquire Labco, one of the largest European operators of medical diagnostic laboratories, from a consortium of investors.   

The acquisition will allow Cinven’s Healthcare and French teams to take advantage of  Labco's success accross a number of areas, including its strong historic financial performance and medical leadership in specialist areas, cementing its position as an attractive investment opportunity.

Jonny Myers, Global Head of Private Equity and partner leading the Clifford Chance team, comments:

'This is a very exciting deal for our client and our team, consisting of lawyers from Paris and London, is delighted to support on this acquisition which brings Cinven a number of attractive opportunities. Cinven's strong  European network and knowledge in Healthcare, combined with Labco's success in this market and sector, makes them a perfect fit to provide a solid platform for future success.' 

Based in Paris and London, the Clifford Chance team was led by Jonny Myers, along with partners Laurent Schoenstein, Gilles Lebreton, Alastair Mordaunt and Fabio Diminich. The partners were supported by senior associates Claudia Kim, Chris Sullivan and Petra Carey; counsels Marion Roquette and Henry Peacock; and lawyers Marie Laure Combet, Valentin Morichon, Valentine Bleicher, Xavier Petet and Oliver Marcuse. The firm advised on the corporate, antitrust and financing aspects of the deal.